| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
37,623 |
34,927 |
$13.25M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,889 |
29,694 |
$5.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,427 |
19,483 |
$5.24M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,700 |
11,638 |
$1.45M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,889 |
7,725 |
$1.01M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,744 |
8,568 |
$711K |
| 36415 |
Collection of venous blood by venipuncture |
32,111 |
28,218 |
$454K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,302 |
14,422 |
$325K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,271 |
3,100 |
$278K |
| J7050 |
Infusion, normal saline solution, 250 cc |
509 |
445 |
$207K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,411 |
1,384 |
$170K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,916 |
8,619 |
$149K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,129 |
2,766 |
$135K |
| 71046 |
Radiologic examination, chest; 2 views |
2,981 |
2,745 |
$110K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,191 |
17,805 |
$100K |
| 80053 |
Comprehensive metabolic panel |
13,460 |
12,271 |
$73K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
742 |
627 |
$66K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
681 |
656 |
$60K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
260 |
251 |
$57K |
| 99233 |
Prolong inpt eval add15 m |
821 |
232 |
$55K |
| G0378 |
Hospital observation service, per hour |
399 |
274 |
$54K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
768 |
713 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
50,640 |
46,390 |
$46K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
615 |
596 |
$45K |
| 99223 |
Prolong inpt eval add15 m |
292 |
266 |
$37K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,157 |
664 |
$31K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
660 |
639 |
$29K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
606 |
231 |
$28K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
272 |
241 |
$25K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
271 |
265 |
$19K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
78 |
74 |
$19K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
405 |
201 |
$15K |
| 99220 |
|
126 |
124 |
$15K |
| J3490 |
Unclassified drugs |
73 |
68 |
$13K |
| 81001 |
|
12,077 |
11,106 |
$13K |
| 84484 |
|
5,439 |
4,222 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
148 |
144 |
$9K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
7,935 |
5,790 |
$8K |
| 92015 |
Determination of refractive state |
317 |
299 |
$7K |
| 88307 |
|
53 |
49 |
$5K |
| 99217 |
|
112 |
112 |
$5K |
| A9270 |
Non-covered item or service |
3,191 |
1,015 |
$5K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
105 |
103 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,305 |
8,276 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,038 |
1,029 |
$4K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
34 |
24 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
33 |
32 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
175 |
167 |
$2K |
| 83690 |
|
2,022 |
1,835 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
131 |
114 |
$2K |
| 84703 |
|
594 |
568 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,695 |
1,484 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$1K |
| 76820 |
|
39 |
25 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,632 |
947 |
$908.01 |
| 99460 |
|
12 |
12 |
$875.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
264 |
256 |
$871.11 |
| 85027 |
|
978 |
857 |
$738.47 |
| 80076 |
|
38 |
37 |
$685.78 |
| 92060 |
|
14 |
13 |
$653.10 |
| 84702 |
|
583 |
521 |
$568.61 |
| 97803 |
|
29 |
27 |
$527.77 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
15 |
$310.31 |
| 85610 |
|
49 |
44 |
$265.22 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
306 |
261 |
$181.60 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
460 |
394 |
$150.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,360 |
1,155 |
$117.81 |
| 83735 |
|
129 |
119 |
$113.63 |
| 83605 |
|
183 |
133 |
$109.61 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
411 |
384 |
$104.64 |
| 81025 |
|
51 |
50 |
$74.18 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
933 |
856 |
$71.06 |
| 82077 |
|
12 |
12 |
$37.37 |
| 83880 |
|
14 |
12 |
$34.07 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
473 |
404 |
$19.22 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
290 |
258 |
$18.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
35 |
25 |
$13.80 |
| 82962 |
|
198 |
40 |
$11.31 |
| 85379 |
|
12 |
12 |
$7.49 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
29 |
26 |
$0.99 |
| J2704 |
Injection, propofol, 10 mg |
15 |
12 |
$0.00 |
| 87081 |
|
137 |
130 |
$0.00 |
| 87807 |
|
13 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
197 |
190 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
13 |
$0.00 |